Search research articles
Contact Us
Filters
Showing results (11-20 of 78) with videos related to
Page
of 8
Sort By:
Frontiers in Medicine
|
September 9, 2020
Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
Vesna Brglez, Sonia Boyer-Suavet, Kévin Zorzi, et al.
Medecine Sciences : M/S
|
June 19, 2014
[New physiopathological roles for the PLA2R1 receptor in cancer and membranous nephropathy]
Christophe A Girard, Barbara Seitz-Polski, Guillaume Dolla, et al.
Bulletin Du Cancer
|
September 2, 2022
[The fight against scientific fraud: A thankless but necessary task]
Jérôme Barrière, Fabrice Frank, Lonni Besancon, et al.
JAMA Dermatology
|
November 30, 2022
Tocilizumab for Corticosteroid-Refractory Immune Checkpoint Inhibitor-Induced Generalized Morphea
Manon Blaise, Nathalie Cardot-Leccia, Barbara Seitz-Polski, et al.
Kidney International Reports
|
March 30, 2026
Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy
Yousra Cheddadi, Mounir El Maï, Vesna Brglez, et al.
Renal Failure
|
March 27, 2025
Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature
Pierre-Alexis Gauci, Marion Cremoni, Jérôme Delotte, et al.
Frontiers in Immunology
|
April 11, 2022
Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities
Michael Levraut, Cassandre Landes, Lydiane Mondot, et al.
Clinical Biochemistry
|
October 23, 2020
Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits
Aurélie Truffot, Jean-François Jourdil, Barbara Seitz-Polski, et al.
Neurology and Therapy
|
June 9, 2018
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders
Christine Lebrun, Mikael Cohen, Maria Alessandra Rosenthal-Allieri, et al.
BMJ Open
|
April 3, 2025
Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial
Maxime Teisseyre, Alexandre Destere, Marion Cremoni, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 78) with videos related to
Sort By:
Page
of 8
Frontiers in Medicine
|
September 9, 2020
Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
Vesna Brglez, Sonia Boyer-Suavet, Kévin Zorzi, et al.
Medecine Sciences : M/S
|
June 19, 2014
[New physiopathological roles for the PLA2R1 receptor in cancer and membranous nephropathy]
Christophe A Girard, Barbara Seitz-Polski, Guillaume Dolla, et al.
Bulletin Du Cancer
|
September 2, 2022
[The fight against scientific fraud: A thankless but necessary task]
Jérôme Barrière, Fabrice Frank, Lonni Besancon, et al.
JAMA Dermatology
|
November 30, 2022
Tocilizumab for Corticosteroid-Refractory Immune Checkpoint Inhibitor-Induced Generalized Morphea
Manon Blaise, Nathalie Cardot-Leccia, Barbara Seitz-Polski, et al.
Kidney International Reports
|
March 30, 2026
Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy
Yousra Cheddadi, Mounir El Maï, Vesna Brglez, et al.
Renal Failure
|
March 27, 2025
Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature
Pierre-Alexis Gauci, Marion Cremoni, Jérôme Delotte, et al.
Frontiers in Immunology
|
April 11, 2022
Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities
Michael Levraut, Cassandre Landes, Lydiane Mondot, et al.
Clinical Biochemistry
|
October 23, 2020
Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits
Aurélie Truffot, Jean-François Jourdil, Barbara Seitz-Polski, et al.
Neurology and Therapy
|
June 9, 2018
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders
Christine Lebrun, Mikael Cohen, Maria Alessandra Rosenthal-Allieri, et al.
BMJ Open
|
April 3, 2025
Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial
Maxime Teisseyre, Alexandre Destere, Marion Cremoni, et al.
Page
of 8